Lexogen Appoints Stéphane Barges as New CEO

Stéphane Barges succeeds Alexander Seitz, MD, the company's founder who will take on the role as Chief Innovation Officer. Stéphane Barges succeedsAlexander Seitz, MD, the company's founder who will take on the role as Chief Innovation Officer. "I am delighted to welcome Stéphane to our company," said Dr. Seitz. "He brings on deep knowledge of commercial operations with proven track records in the life sciences and diagnostics industries. With a significant international exposure,...

VIENNA, 04/08/2020 (informazione.it - comunicati stampa - salute e benessere)

Stéphane Barges succeeds Alexander Seitz, MD, the company's founder who will take on the role as Chief Innovation Officer.

"I am delighted to welcome Stéphane to our company," said Dr. Seitz. "He brings on deep knowledge of commercial operations with proven track records in the life sciences and diagnostics industries. With a significant international exposure, Stéphane is recognized for his outstanding leadership and I am confident that he will successfully drive the expansion of Lexogen."

Stéphane Barges holds a doctorate in Genetics and Molecular biology from the University of Geneva (Switzerland) and an MBA in International Management from HEC Geneva. He has 20 years of experience in a wide range of management positions in the life science and clinical diagnostics industry. Since 2005, he has worked in various commercial areas and held diverse positions with increasing management responsibility in the industry leaders (Life Technologies, Bio-Rad, and Tecan), most recently as a Vice President in the Molecular Diagnostics division of QIAGEN.

About Lexogen

Established in 2007, Lexogen is a transcriptomics and Next-Generation Sequencing company, focusing on the development of innovative methods for RNA analysis. Its portfolio includes multiple innovative and well-established protocols for RNA sequencing sample preparation, external RNA spike-in controls, as well as bioinformatics tools and sequencing services. Lexogen is a privately held company, headquartered in Vienna, Austria with a subsidiary in New Hampshire, US.